During the last session, Neurogene Inc (NASDAQ:NGNE)’s traded shares were 0.19 million, with the beta value of the company hitting 1.58. At the end of
Neurogene Inc (NASDAQ:NGNE)’s traded shares stood at 0.64 million during the last session, with the company’s beta value hitting 1.66. At the close of trading,
In last trading session, Neurogene Inc (NASDAQ:NGNE) saw 0.34 million shares changing hands with its beta currently measuring 1.64. Company’s recent per share price level
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
